Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Survey Shows That One Third Of Women (Ages 20 to 39) Polled Have Removed A Photo From Social Media To Hide Their Acne(1)

ACZONE® (dapsone) Gel 5%, the #1 prescribed non-retinoid branded acne treatment, releases survey results about common skin concerns, acne treatment behavior, and the relationship between acne and women's social media habits(1)(2)


News provided by

Allergan plc

Dec 17, 2015, 08:00 ET

Share this article

Share toX

Share this article

Share toX

IRVINE, Calif., Dec. 17, 2015 /PRNewswire/ -- Today's society is saturated with social media; it has become the channel people use to share their daily lives through photos and captions. According to a new U.S. survey conducted by TotalBeauty and ACZONE® (dapsone) Gel 5%, a prescription medicine used on your skin (topical) to treat acne vulgaris, acne concerns affected the social media habits of women ages 20 to 39 (n=480) when it came to photos.1,3 Of the women surveyed, two in five (n=212) admitted to editing a photo to hide their acne, while one third of the women (n=171) had gone as far as to remove or un-tag a photo on their social media pages simply because of their acne.1

Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO

Acne was the dominant skin concern among the women surveyed (n=220).1 In fact, acne is the most common skin condition in the United States, experienced by nearly 85% of people.4 It is important for acne sufferers to see a dermatologist, but of the women surveyed, sixty-five percent (n=313) had self-treated their acne before doing so.1 While there are many different treatment options, more than half of women (n=274) reported that they would consider using a prescription medication to treat their acne.1

"These survey results reflect what I often see in my office every day. Many of my patients feel like they're alone in their acne journey and find it frustrating and difficult to understand when breakouts progress into adulthood. Although acne is a chronic condition, it can be managed and treated.5 If you find yourself experiencing breakouts, talk to your dermatologist about treatment options that are right for you," says celebrity dermatologist Whitney Bowe, M.D.

Dr. Whitney Bowe recommends the following tips:

  • Don't stop your acne treatment.6 "I tell my patients that it's important to give their treatment time to work.7 One medication I often prescribe to my acne patients 12 years or older is ACZONE® Gel.It is the only acne treatment with active ingredient topical dapsone and treats inflammatory and noninflammatory acne.3,8
  • Break a sweat. "Exercise is one of my favorite ways to reduce stress and increase blood flow, which can benefit the skin."9 Dr. Bowe suggests sending free radicals packing with at least 10 minutes of running a day on the treadmill.10
  • Check your diet. "Although there is no proven link between diet and acne, low glycemic diets have been associated with low levels of acne.11,12 Some of my favorite low-glycemic foods are non-starchy vegetables, steel-cut oatmeal and fruit."13

APPROVED USE

ACZONE® (dapsone) Gel 5% is a prescription medicine used on your skin (topical) to treat acne vulgaris.

IMPORTANT SAFETY INFORMATION

Tell your doctor about all of your medical conditions, including if you have; glucose-6-phosphatedehydrogenase deficiency (G6PD) or higher than normal levels of methemoglobin in your blood (methemoglobinemia). Talk to your doctor about any medications you're using including topical benzoyl peroxide (BPO). Use of BPO with ACZONE® Gel may cause your skin and facial hair to temporarily turn yellow or orange at the site of application.

ACZONE® Gel, 5% may cause serious side effects, including:

  • a decrease of oxygen in your blood caused by a certain type of abnormal red blood cell (methemoglobinemia). If your lips, nail beds or the inside of your mouth turns grey or blue, stop using ACZONE® Gel 5% and get medical help right away.
  • a breakdown of red blood cells (hemolytic anemia) for some people with G6PD deficiency using ACZONE® Gel 5%. If you get any of the following signs and symptoms such as back pain, breathlessness, tiredness/weakness, dark-brown urine, fever, and yellow or pale skin, stop using ACZONE® Gel 5% and call your doctor right away.

The most common side effects of ACZONE® Gel are dryness, redness, oiliness, and peeling of the skin being treated.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information 
Click here to visit the ACZONE® website  
Click here for Privacy Statement and Terms of Use

Survey Methodology

The survey was conducted by TotalBeauty among 480 women in the United States, ages 20 – 39, between June 23, 2015 and July 9, 2015 using an email invitation, social media posts and an online survey.

© 2015 Allergan. All rights reserved.
® marks owned by Allergan

APC37OI15

1 Survey. TotalBeauty.com. TotallyHer Media LLC, July 9, 2015.
2 IMS Health, Inc. Vector One®: National (VONA).Plymouth Meeting, PA: IMS Health, Inc.; Total prescriptions filled for non-retinoid acne treatments between February 2014-January 2015.
3 ACZONE®(dapsone) Gel 5% U.S. Prescribing Information.
4 American Academy of Dermatology. "Stats and Facts: Acne." Available online at http://www.aad.org/media-resources/stats-and-facts/conditions/acne. Last accessed on May 15, 2014. 
5 Gollnick H et al. Can We Define Acne as a Chronic Disease?. Am J Clin Dermatol. 2008:9(5): 279-284.
6 American Academy of Dermatology. "Acne Scars" Tips for Preventing." Available online at: https://www.aad.org/dermatology-a-to-z/diseases-and-treatments/a---d/acne-scars/tips-for-preventing Last accessed on March 5, 2015.
7 Draelos.Clincal Situations Conducive to Proactive Skin Health and Anti-Aging Improvement. Journal of Investigative Dermatology Symposium Proceedings. 2008: 13: 25–27
8 U.S. Food and Drug Administration (FDA). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Available at: http://www.accessdata.fda.gov/scripts/cder/ob/. Accessed May 1, 2015.
9 Jaret, P. "Exercise for Healthy Skin." Available online at: http://www.webmd.com/skin-problems-and-treatments/acne/features/exercise. Last accessed on January 8, 2015.  
10 Mayo Clinic. "Stress Management". Available online at: http://www.mayoclinic.org/healthy-living/stress-management/in-depth/exercise-and-stress/art-20044469?pg=2. Last accessed February 27, 2015.
11 American Academy of Dermatology. "Diet and acne." Available online at: https://www.aad.org/dw/monthly/2012/acne/diet-and-acne#allpages. Last accessed on March 18, 2015.Mayo Clinic. "Stress Management". Available online at: http://www.mayoclinic.org/healthy-living/stress-management/in-depth/exercise-and-stress/art-20044469?pg=2. Last accessed February 27, 2015.
12 Melnik, B.et al. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol. 2009: 18(10). 833-41.
13 American Diabetes Association. "Glycemic Index and Diabetes." Available online at: http://www.diabetes.org/food-and-fitness/food/what-can-i-eat/understanding-carbohydrates/glycemic-index-and-diabetes.html. Last accessed on February 25, 2015.

MEDIA CONTACT:
Jessica Chao
[email protected] 
(714) 246-3151

SOURCE Allergan plc

Related Links

http://www.allergan.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.